BML Inc operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BML Inc with three other
pharmaceutical manufacturers in Asia:
Falco Holdings Co Ltd
sales of 58.40 billion Japanese Yen [US$487.65 million]
of which 50%
was Medical Test),
Zhejiang DiAn Diagnostics Co Ltd
(1.33 billion Chinese Renmimbi [US$215.13 million]
of which 62%
was Service), and
Medical & Biological Laboratories Company Limited
(7.17 billion Japanese Yen [US$59.89 million]
of which 100%
was Reagent business).
BML Inc reported sales of ¥99.05 billion (US$827.04 million)
March of 2014.
increase of 4.7%
versus 2013, when the company's sales were ¥94.61 billion.
Sales at BML Inc have increased during each of the previous five years
(and since 2009, sales have increased a total of 28%).